MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

HPRT1 Gene Mutation in a Young Male with Early Childhood Onset Seizures-Parkinsonism and Levodopa-Induced Dyskinesia: A Case Report

A. Mansour, A. Kilany (Cairo, Egypt)

Meeting: 2025 International Congress

Keywords: Parkinsonism

Category: Parkinsonism (Other)

Objective: To report the clinical course, diagnostic evaluation, and genetic findings in a 24-year-old male with early childhood onset tremor, seizures ,bradykinesia and  rigidity , In addition to levodopa-induced dyskinesia.

Background: Early-onset Seizures-parkinsonism with levodopa-induced dyskinesia is a rare presentation. Genetic mutations, such as in the HPRT1 gene, can play a crucial role in the pathophysiology of Hyperkinetic Movement Disorders.

The HPRT1 gene encodes the enzyme hypoxanthine-guanine phosphoribosyl transferase 1 (HGPRT), essential for purine recycling in nucleotide metabolism. Mutations in HPRT1 can lead to varying degrees of enzyme deficiency, resulting in disorders such as Lesch-Nyhan syndrome (LNS) and hyperuricemia. LNS is characterized by hyperuricemia, choreoathetosis, and self-mutilating behaviors. To date, there have been no documented cases linking HPRT1 mutations to parkinsonism, seizures, or levodopa-induced dyskinesia.

This case highlights the diagnostic journey and clinical management of a young male with this presentation.

Method: A comprehensive clinical evaluation, brain MRI, EEG, routine laboratory tests, metabolic screening (serum pyruvate, lactate, copper, ceruloplasmin, and 24-hour urinary copper), and whole exome sequencing were conducted.

Results: The patient experienced tremors since the age of 4, with progressive bradykinesia and rigidity. He had a history of generalized tonic-clonic seizures from age 4, which recurred annually until the age of 15. Episodes of leg elevation with confusion and disturbed consciousness upon entering sleep were also reported. MRI and metabolic tests were unremarkable. Whole exome sequencing revealed a pathogenic mutation in the HPRT1 gene. Thus, reporting the first case presenting with early childhood onset Parkinsonism along with seizures in addition to levodopa induced dyskinesia related to mutation in this gene.

Conclusion: This case underscores the importance of genetic testing in diagnosing atypical parkinsonian syndromes, particularly in young patients with an unusual clinical presentation. Early genetic diagnosis can aid in personalized management and genetic counseling.

To cite this abstract in AMA style:

A. Mansour, A. Kilany. HPRT1 Gene Mutation in a Young Male with Early Childhood Onset Seizures-Parkinsonism and Levodopa-Induced Dyskinesia: A Case Report [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/hprt1-gene-mutation-in-a-young-male-with-early-childhood-onset-seizures-parkinsonism-and-levodopa-induced-dyskinesia-a-case-report/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/hprt1-gene-mutation-in-a-young-male-with-early-childhood-onset-seizures-parkinsonism-and-levodopa-induced-dyskinesia-a-case-report/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley